Xvivo Perfusion: Receives patent for Perfadex Plus

Research Note

2019-08-21

11:42

Xvivo Perfusion announces that the company has received a patent approval for Perfadex Plus, a second-generation of the lung preservation solution Perfadex.

AN

Arvid Necander

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.